Popular Articles

Amarillo Biosciences And CytoPharm Announce Start Of Enrollment For Hepatitis C Study In Taiwan
Amarillo Biosciences, Inc. (ABI) (OTCBB: AMAR) and CytoPharm, Inc. today jointly announced the start of enrollment for a study of ABI"s oral interferon-alpha lozenges for chronic hepatitis C virus infection. The aim of the trial is to reduce the virologic relapse rate for those patients who have completed the standard combination therapy, which consists of high dose injectable interferon-alpha and Ribavirin. Although most patients respond to the standard therapy, up to 50% of those with certain "high-risk" viral genotypes relapse after treatment.
generic viagra online
Demonstrators Gather At Washington, D.C., CVS Pharmacy To Protest Practice Of Locking Up Condoms
Protesters gathered outside a Washington, D.C., CVS Pharmacy on Thursday to urge the pharmacy chain to end the practice of locking condoms in display cases in certain neighborhoods, WJLA News reports. The protesters contend that CVS restricts access to condoms in poor black neighborhoods, whose residents may be at higher risk for HIV, other sexually transmitted infections and unintended pregnancies (WJLA News, 6/11). The protest was a part of a nationwide effort called, "Cure CVS: Unlock the Condoms Initiative," which aims to urge CVS to keep condoms unlocked at all times (Business Wire release, 6/10). CVS said in a statement, "All CVS stores sell condoms that are unlocked and accessible" (WJLA News, 6/11).
News of the day
TB Booster Vaccine Trials To Begin Next Month In South Africa
A new two-year trial to test a tuberculosis vaccine aimed at boosting the efficacy of the BCG vaccine is scheduled to begin soon in South Africa, IRIN reports (IRIN, 6/4). The vaccine candidate, called MVA85A, will be tested next month in 2,874 children younger than age one. The new tests will be the "first concept trial of a new preventative TB vaccine for infants in close to 90 years," according to Reuters.
Endocrinology

Montgomery County, Ala., Has Highest HIV/AIDS Rate In State

There were 839 reported cases of HIV/AIDS in Alabama in 2008, and of those 122 were reported in Montgomery County, which had the highest number in the state per capita, the Montgomery Advertiser reports. Black residents comprised 70 percent of all HIV/AIDS cases in Alabama reported that year. Poverty, lack of transportation to health services, not knowing a partner"s status and not getting tested are cited as factors contributing to the greater risk for HIV among blacks in the state, according to the Advertiser. Jane Cheeks, director of HIV/AIDS programs for the Alabama Department of Public Health, said, "The more we test, the more we find," adding, "But we"re hoping we can lower the infection rate." She also said, "In 2007, we got a pretty significant increase in funding and we were able to provide more services and give more testing." In addition to administering HIV tests, the "state educates the public through public service announcements and rolling billboards on the sides of 18-wheelers, which give people toll-free numbers to call" for information, the article states (Klass, 7/11). This information was reprinted from dailyreports.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily U.S. HIV/AIDS Report, search the archives and sign up for email delivery at dailyreports.kff.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):